FNDC5 and Obesity: Numerous interventional studies in animal models of diabetes and/or obesity have shown that the exogenous administration of recombinant irisin can restore glucose and lipid homeostasis, thus exerting antidiabetic and antiobesity effects [5,52,53,54,55,56,57].